The US Supreme Court has aided President Donald Trump in his mission to plough on with a major workforce reduction and agency overhaul impacting the US Department of Health and Human Services (HHS).

Japanese authorities are putting Eisai (TSE: 4523) under pressure to reconsider the price of its Alzheimer’s disease therapy ...

US pharma major Eli Lilly’s orforglipron is emerging as a promising oral glucagon-like peptide (GLP)-1 therapy, with upcoming clinical milestones in obesity and diabetes set to shape its market ...

French biotech Inventiva has changed up its executive team as it continues to bet on experimental MASH therapy lanifibranor, ...

The USA’s Federal Trade Commission is sending payments totaling more than $409,000 to consumers who bought products from ...

Singapore-based market expansion services provider DKSH Business Unit Healthcare announced a partnership with Germany’s Bayer ...

Radiant Biotherapeutics, a Canadian biotech advancing multi-specific, multi-affinity antibody (Multabody) therapeutics in ...

Dutch privately held Amarna Therapeutics, which specializes in transformative gene therapies announced the formalization of ...

Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...

The US Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for ...

US clinical-stage biotech ProKidney reported statistically-significant and clinically-meaningful positive top-line results ...

US antivirals specialist Gilead Sciences today announced a strategic partnership agreement with the Global Fund to Fight AIDS ...